China Approves First Hepatitis D Drug After 13 Years
A groundbreaking hepatitis D treatment just won approval in China, offering hope to 12 million people worldwide living with one of the most severe forms of viral hepatitis. The drug represents a rare full-journey innovation, from basic science discovery to market-ready medicine, all developed domestically.
